PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 5102 (109th)

Medicare Drug Formulary Protection Act

referredUnited States· United States Congress· EN

Introduced

5 April 2006

Last action

19 April 2006 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

XAVIER BECERRA, PETER DEFAZIO, Rep. Salazar, John T. [D-CO-3], Rep. Honda, Michael M. [D-CA-17], Rep. Jefferson, William J. [D-LA-2], Rep. Kennedy, Patrick J. [D-RI-1], Rep. Boucher, Rick [D-VA-9], Rep. Wexler, Robert [D-FL-19], Rep. Cardoza, Dennis A. [D-CA-18], James McGovern, Rep. Mollohan, Alan B. [D-WV-1], GENE GREEN, Raúl Grijalva, Rep. Rangel, Charles B. [D-NY-19], Rep. Stark, Fortney Pete [D-CA-9], JOHN CONYERS, Rep. McDermott, Jim [D-WA-7], Rep. Herseth Sandlin, Stephanie [D-SD-At Large], Rep. Hinchey, Maurice D. [D-NY-22], Sen. Brown, Sherrod [D-OH], Rep. Reyes, Silvestre [D-TX-16], C. Ruppersberger, John Larson, Rep. McNulty, Michael R. [D-NY-23], Rep. Matsui, Doris O. [D-CA-7], Rep. Costello, Jerry F. [D-IL-21], CAROLYN MALONEY, Rep. Marshall, Jim [D-GA-8], SANDER LEVIN, Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Inslee, Jay [D-WA-1], Rep. Lynch, Stephen F. [D-MA-8], Rep. Delahunt, Bill [D-MA-10], Rep. Owens, Major R. [D-NY-12], Rep. Ortiz, Solomon P. [D-TX-27], Rep. Schakowsky, Janice D. [D-IL-9], Grace Napolitano, TIM RYAN, MIKE DOYLE, Rep. Pomeroy, Earl [D-ND-At Large], Rep. Scott, Robert C. "Bobby" [D-VA-3], Rep. Baca, Joe [D-CA-43], Sen. Sanders, Bernard [I-VT], ELIJAH CUMMINGS, Rep. Oberstar, James L. [D-MN-8], Rep. Payne, Donald M. [D-NJ-10], Rep. Gonzalez, Charles A. [D-TX-20], Rep. Emanuel, Rahm [D-IL-5]

Subjects

Healthcare

Source updated

15 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Medicare Drug Formulary Protection Act - Amends title XVIII (Medicare) of the Social Security Act to prohibit removal of covered part D (Voluntary Prescription Drug Benefit Program) drugs from a prescription drug plan formulary, or imposition of a restriction or limitation on the coverage of such a drug, during the plan year: (1) except at the beginning; or (2) for an individual enrollee, from the date of enrollment until December 31 of the immediately succeeding plan year. Specifies exceptions to such prohibition. Requires an annual notice to enrollees of changes in formulary and other restrictions or limitations on coverage.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 5 April 2006

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 5 April 2006

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 5 April 2006

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 5 April 2006

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 19 April 2006

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Showing 48 of 65 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.